Inovio partners with Advaccine to commercialize COVID-19 vaccine in China

 Inovio Pharmaceuticals Inc has partnered with Advaccine Biopharmaceuticals Suzhou Co Ltd to manufacture and commercialize its COVID-19 vaccine candidate in China, the companies said on Monday.

Under the agreement, Advaccine will have the exclusive right to develop, manufacture and commercialize Inovio's vaccine candidate, INO-4800, in the country.

https://www.marketscreener.com/quote/stock/INOVIO-PHARMACEUTICALS-I-17937428/news/Inovio-Pharmaceuticals-partners-with-Advaccine-to-commercialize-COVID-19-vaccine-in-China-32116079/